LA Jolla Pharma (LJPC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
6.22 unch (unch) 08/19/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 6.22 unch (unch) -
for Fri, Aug 19th, 2022
Results
download Want to compare other data? Select Fields| Symbol | LJPC | IKT | FDMT | ||
| Company | LA Jolla Pharma | Inhibikase Therapeutics Inc | 4D Molecular Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.21 | 2.18 | 3.31 | ||
| High | 6.24 | 2.26 | 3.44 | ||
| Low | 6.20 | 2.13 | 3.21 | ||
| Last | 6.22 | 2.25 | 3.24 | ||
| Change | unch | +0.05 | -0.10 | ||
| % Change | unch | +2.27% | -2.99% | ||
| Volume | 267,600 | 131,400 | 354,800 | ||
| 20-Day Average Volume | 349,385 | 141,375 | 754,265 | ||
| Previous Close | 6.22 | 2.20 | 3.34 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.20 | 1.99 | 3.00 | ||
| 20-Day Raw Stochastic | 95.24% | 97.93% | 66.89% | ||
| 20-Day Relative Strength | 76.58% | 52.52% | 45.38% | ||
| Weighted Alpha | +7.10 | +15.93 | -82.20 | ||
| Today's Opinion | 100% Buy | 16% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 32% Sell | 88% Sell | ||
| Last Month's Opinion | 40% Buy | 8% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 08/12/22 | +14.80% since 04/22/25 | -4.71% since 04/22/25 | ||
| Low | 5.82 on 08/17/22 | 2.01 on 04/23/25 | 3.17 on 04/25/25 | ||
| High | 6.24 on 08/19/22 | 2.26 on 04/29/25 | 3.74 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +0.48% since 07/19/22 | -1.75% since 03/28/25 | -10.74% since 03/28/25 | ||
| Low | 5.82 on 08/17/22 | 1.54 on 04/07/25 | 2.23 on 04/09/25 | ||
| High | 6.24 on 08/19/22 | 2.33 on 03/31/25 | 3.74 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | +53.20% since 05/19/22 | -19.64% since 01/29/25 | -35.20% since 01/29/25 | ||
| Low | 3.07 on 07/05/22 | 1.54 on 04/07/25 | 2.23 on 04/09/25 | ||
| High | 6.24 on 08/19/22 | 3.32 on 02/21/25 | 6.91 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | +48.45% since 02/18/22 | -14.77% since 10/29/24 | -60.49% since 10/29/24 | ||
| Low | 3.07 on 07/05/22 | 1.54 on 04/07/25 | 2.23 on 04/09/25 | ||
| High | 6.24 on 08/19/22 | 4.20 on 12/18/24 | 9.18 on 11/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 155,108 | 163,552 | 154,649 | ||
| Shares Outstanding, K | 24,937 | 74,342 | 46,302 | ||
| Annual Sales | 75,720,000 | 0 | 40,000 | ||
| Annual Net Income | 19,660,000 | -27,520,000 | -160,870,000 | ||
| Last Quarter Sales | 10,430,000 | 0 | 0 | ||
| Last Quarter Net Income | 0 | -12,130,000 | -43,840,000 | ||
| 60-Month Beta | 2.39 | 1.02 | 2.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.08 on 08/15/22 | -0.65 on 11/14/24 | -0.90 on 02/28/25 | ||
| Latest Earnings Date | 08/18/22 | 05/21/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 51.83 | 0.00 | 0.00 | ||